Imatinib, Dasatinib or Nilotinib

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Pivotal Study of HQP1351 in Patients With Chronic Myeloid Leukemia in Chronic PhaseNCT04126681Ascentage Pharma Group Inc.Phase 2Completed2024-08-01Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.